Daily BriefsSouth Korea

Daily Brief South Korea: LG Electronics, Samsung Biologics and more

In today’s briefing:

  • LG Electronics: A SELL Candidate Amid Difficult Business Condition for Consumer Electronics in 2023
  • Samsung Biologics (207940 KS): Near-Term Key Positive Catalysts

LG Electronics: A SELL Candidate Amid Difficult Business Condition for Consumer Electronics in 2023

By Douglas Kim

  • After a disappointing earnings results in 4Q 2022, we believe LG Electronics (066570 KS) is a SELL candidate.
  • The decline in housing prices in major countries such as the US and South Korea have negatively impacted consumers’ purchases of consumer appliances. 
  • With the consensus that is likely to cut their operating profit estimates significantly in 2023, we think that LG Electronics’ shares could fall another 20-25% over the next year. 

Samsung Biologics (207940 KS): Near-Term Key Positive Catalysts

By Tina Banerjee

  • Samsung Biologics (207940 KS) is expected to report strong Q4 results, with double-digit revenue growth. Partial operation of Plant 4 will impact profitability, which will be continued through H12023.
  • The Chairman of the company has been selling shares, causing recent pullback in the stock, which should be considered as an attractive entry point.
  • The long-term growth story remains intact, with all eyes being on upcoming conference where the company may unfold its capex plan amid stellar order book and industry demand.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars